Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin.
about
Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrinAntibodies to serine proteases in the antiphospholipid syndrome.Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus.Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome.Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.Endothelial cell activation by antiphospholipid antibodies is modulated by Kruppel-like transcription factorsApolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome.Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancerA Case of Microangiopathic Antiphospholipid-Associated Syndromes during Pregnancy: Review of the LiteratureAntiphospholipid syndrome and tissue factor: a thrombotic couple.Antiphospholipid antibodies: laboratory and pathogenetic aspects.Platelets and the antiphospholipid syndrome.Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases.Some antiphospholipid antibodies bind to hemostasis and fibrinolysis proteases and promote thrombosis.C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodiesAntiphospholipid syndrome treatment beyond anticoagulation: are we there yet?Potential use of statins in the treatment of antiphospholipid syndrome.Antiphospholipid syndrome: 30 years and our contribution.The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome.Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus.Platelet-Derived S100A8/A9 and Cardiovascular Disease in Systemic Lupus Erythematosus.Role of apolipoprotein B100 and oxidized low-density lipoprotein in the monocyte tissue factor induction mediated by anti-β2 glycoprotein I antibodies.Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis.Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?Diagnosis and management of the antiphospholipid syndrome.Novel therapies for the antiphospholipid syndrome.C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies.In search for a receptor for antiphospholipid antibodies on target cells.
P2860
Q33511345-EB22E609-D956-411F-971B-B3056EFE4512Q33670367-759078A4-02CF-400B-A4D4-D196B8F1F7A1Q33748970-74EB8DFE-F398-4F02-AC85-EF36AE84FEB0Q34287356-0ABBC234-E19E-461E-8E1F-82CE75DF5A6EQ34749444-55580A81-CFEF-49D5-A4DF-65DFA8188A23Q35067429-C6550D18-59D8-402C-8A71-8FD276D64814Q35874202-9E95C09F-86C6-4C8B-9F3E-43222821F95CQ36090335-BD293532-A08A-4C52-9A66-AFE38BB98F60Q36090804-D302CECE-5ED1-42BB-B970-E6E8169FC77CQ36458154-C145534B-638B-44A4-891B-064AF39D8783Q36799474-766F264F-1E52-4C16-BF42-F1F7BA1959F6Q37283013-A3BA7009-4BB6-4D5A-8E0D-217B8B17E56BQ37283020-08BAC630-B678-40F2-8FBE-9CC93A538133Q37283026-117690F3-C67F-4B09-9DA0-DB7CC7DD1FB5Q37581827-448140DD-5438-49E2-98C0-AAFE301B91B6Q37721617-1D200002-8FAC-4421-A896-2AD3055C4C7EQ37959316-775F96ED-CD66-4493-8ACF-DA7C406E1B62Q38294180-1157F0EF-1148-4C4E-B941-98CF7B8E1B38Q38374306-F1E51D96-DF6F-4149-B8F7-4D8DF39138BDQ38657043-32C3BCD4-072E-4C6E-8104-1BB33834DB3FQ38777078-35710279-055B-427C-821A-6297B83BC2DBQ38899360-B812708C-7108-40A5-AEC7-4BB6637FA5AEQ39931228-2188834E-44D0-4E75-8D81-5ED510711F20Q46252434-71398314-D9A3-47FE-BED9-E048D177B08AQ46275219-567A580A-12E0-4F1C-A4E3-8FD27A87D5D2Q47982275-DC460FBC-BD77-4570-9A51-D83B2C52EDD6Q53495449-2EA3103A-9E9A-4A51-8744-4D2CD634DF02Q53525527-4E4E5CE8-8870-422A-A0B5-01F2E590C1AAQ53608100-5E155274-3B0C-42D5-972D-88F83D8A3F4F
P2860
Intracellular events in platelet activation induced by antiphospholipid antibodies in the presence of low doses of thrombin.
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Intracellular events in platel ...... ence of low doses of thrombin.
@ast
Intracellular events in platel ...... ence of low doses of thrombin.
@en
type
label
Intracellular events in platel ...... ence of low doses of thrombin.
@ast
Intracellular events in platel ...... ence of low doses of thrombin.
@en
prefLabel
Intracellular events in platel ...... ence of low doses of thrombin.
@ast
Intracellular events in platel ...... ence of low doses of thrombin.
@en
P356
P1476
Intracellular events in platel ...... ence of low doses of thrombin.
@en
P2093
Mariano Vega-Ostertag
Silvia S Pierangeli
P304
P356
10.1002/ART.20434
P577
2004-09-01T00:00:00Z